Patient 5 was a 30-year-old woman who presented with right locally advanced, estrogen receptor (ER)-positive, progesterone receptor (PR)-negative, HER2-positive breast cancer undergoing neoadjuvant treatment and nipple-sparing mastectomy with implant reconstruction (Fig. 3A). The gene discussed is ERBB2; the disease is breast carcinoma.